XML 57 R32.htm IDEA: XBRL DOCUMENT
v2.4.1.9

Significant Accounting Policies (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2014
Significant Accounting Policies [Abstract] |
Supplemental cash flow information | For purposes of reporting cash flows, cash and cash equivalents include cash on hand and amounts due from banks. The following table reflects specific transaction amounts for the periods presented ($ in thousands):
|  | Years Ended December 31, |
|  | 2014 |  |  | 2013 |  |  | 2012 |
Income taxes paid |  | $ | 13,710 |  |  | $ | 14,520 |  |  | $ | 57,834 |
Interest expense paid on deposits and borrowings |  |  | 22,268 |  |  |  | 25,715 |  |  |  | 31,496 |
Noncash transfers from loans to foreclosed properties (1) |  |  | 39,778 |  |  |  | 41,042 |  |  |  | 37,635 |
Transfer of long-term FHLB advances to short-term |  |  | 6,644 |  |  |  | - |  |  |  | - |
Assets acquired in business combination |  |  | - |  |  |  | 1,845,543 |  |  |  | 234,960 |
Liabilities assumed in business combination |  |  | - |  |  |  | 1,821,066 |  |  |  | 209,322 |
(1) | Includes transfers from covered loans to foreclosed properties.
Schedule of changes in consolidated statements of cash flows | The following table reflects the changes to the Consolidated Statements of Cash Flows for the periods presented ($ in thousands):
|  | As Reported |  |  | Adjustment |  |  | As Adjusted |
Year Ended December 31, 2013: |  |  |  |  |  |  |  |  |
Net cash provided by operating activities |  | $ | 155,417 |  |  | $ | 145,766 |  |  | $ | 301,183 |
Net cash used in investing activities |  |  | (113,201 | ) |  |  | (145,766 | ) |  |  | (258,967 | )
Net cash provided by financing activities |  |  | 72,056 |  |  |  | - |  |  |  | 72,056 |
Increase in cash and cash equivalents |  |  | 114,272 |  |  |  | - |  |  |  | 114,272 |
Cash and cash equivalents at beginning of year |  |  | 231,489 |  |  |  | - |  |  |  | 231,489 |
Cash and cash equivalents at end of year |  | $ | 345,761 |  |  | $ | - |  |  | $ | 345,761 |
Year Ended December 31, 2012: |  |  |  |  |  |  |  |  |  |  |  |
Net cash provided by operating activities |  | $ | 92,125 |  |  | $ | 20,152 |  |  | $ | 112,277 |
Net cash provided by (used in) investing activities |  |  | 193,891 |  |  |  | (20,152 | ) |  |  | 173,739 |
Net cash used in financing activities |  |  | (257,152 | ) |  |  | - |  |  |  | (257,152 | )
Increase in cash and cash equivalents |  |  | 28,864 |  |  |  | - |  |  |  | 28,864 |
Cash and cash equivalents at beginning of year |  |  | 202,625 |  |  |  | - |  |  |  | 202,625 |
Cash and cash equivalents at end of year |  | $ | 231,489 |  |  | $ | - |  |  | $ | 231,489 |
Weighted-average shares used to calculate basic and diluted EPS | The following table reflects weighted-average shares used to calculate basic and diluted EPS for the periods presented (in thousands):
|  | Years Ended December 31, |
|  | 2014 |  |  | 2013 |  |  | 2012 |
Basic shares |  |  | 67,434 |  |  |  | 66,897 |  |  |  | 64,659 |
Dilutive shares |  |  | 160 |  |  |  | 176 |  |  |  | 192 |
Diluted shares |  |  | 67,594 |  |  |  | 67,073 |  |  |  | 64,851 |
Weighted-average antidilutive stock awards excluded from determining diluted EPS | Weighted-average antidilutive stock awards were excluded in determining diluted EPS. The following table reflects weighted-average antidilutive stock awards for the periods presented (in thousands):
|  | Years Ended December 31, |
|  | 2014 |  |  | 2013 |  |  | 2012 |
Weighted-average antidilutive stock awards |  |  | 32 |  |  |  | 333 |  |  |  | 653 |

X
- Definition Tabular disclosure of changes in condensed cash flow statement, including, but not limited to, cash flow statements of consolidated entities and consolidation eliminations. + References No definition available. + Details
Name: | trmk_ScheduleOfChangesInConsolidatedStatementsOfCashFlowsTableTextBlock
Namespace Prefix: | trmk_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_AccountingPoliciesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 + Details
Name: | us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of supplemental cash flow information for the periods presented. + References No definition available. + Details
Name: | us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit). + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 + Details
Name: | us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration